Q1 2025 · 13F-HR
First Light Asset Management, LLCholdings as filed
Filed 2025-05-15 · accession 0001999371-25-006243
$875.7M
Reported value
37
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 032724106 | ANAB | ANAPTYSBIO INC | $86.1M | 9.84% | 4,633,602 | Common | SOLE |
| 05463X106 | AXGN | AXOGEN INC | $82.8M | 9.45% | 4,474,215 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $70.1M | 8.00% | 4,874,124 | Common | SOLE |
| 64049M209 | NEO | NEOGENOMICS INC | $57.3M | 6.55% | 6,042,822 | Common | SOLE |
| 90184D100 | TWST | TWIST BIOSCIENCE CORP | $47.8M | 5.46% | 1,218,699 | Common | SOLE |
| 42225T107 | HCAT | HEALTH CATALYST INC | $47.3M | 5.40% | 10,436,807 | Common | SOLE |
| 04963C209 | ATRC | ATRICURE INC | $42.4M | 4.84% | 1,314,718 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $40.8M | 4.65% | 1,852,290 | Common | SOLE |
| 71377E105 | PFMTUSD | PERFORMANT FINL CORP | $34.6M | 3.95% | 11,693,033 | Common | SOLE |
| 450056106 | IRTC | IRHYTHM TECHNOLOGIES INC | $34.0M | 3.89% | 325,046 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $28.7M | 3.28% | 855,419 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $28.2M | 3.23% | 1,175,879 | Common | SOLE |
| 602496101 | MDXG | MIMEDX GROUP INC | $26.2M | 3.00% | 3,453,074 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $22.9M | 2.61% | 632,033 | Common | SOLE |
| 825704109 | SIBN | SI-BONE INC | $22.6M | 2.58% | 1,612,408 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $21.1M | 2.41% | 627,904 | Common | SOLE |
| 641288105 | NPCE | NEUROPACE INC | $19.5M | 2.22% | 1,584,048 | Common | SOLE |
| 01625V104 | ALHC | ALIGNMENT HEALTHCARE INC | $17.8M | 2.03% | 956,441 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $17.8M | 2.03% | 658,824 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $13.7M | 1.57% | 336,870 | Common | SOLE |
| 124155102 | BFLY | BUTTERFLY NETWORK INC | $12.6M | 1.43% | 5,505,649 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $11.5M | 1.32% | 271,115 | Common | SOLE |
| 759910102 | KRMD | KORU MEDICAL SYSTEMS INC | $11.3M | 1.29% | 4,454,926 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $11.2M | 1.28% | 87,850 | Common | SOLE |
| 28617K101 | ELDN | ELEDON PHARMACEUTICALS INC | $7.9M | 0.90% | 2,328,768 | Common | SOLE |
| 65443P102 | MASS | 908 DEVICES INC | $7.6M | 0.87% | 1,701,095 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $7.3M | 0.83% | 107,860 | Common | SOLE |
| 687793109 | OSCR | OSCAR HEALTH INC | $6.8M | 0.78% | 522,302 | Common | SOLE |
| 69913P105 | FNAUSD | PARAGON 28 INC | $6.5M | 0.75% | 500,000 | Common | SOLE |
| 30050B101 | EVH | EVOLENT HEALTH INC | $5.5M | 0.63% | 585,436 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $5.2M | 0.59% | 68,153 | Common | SOLE |
| 875372203 | TNDM | TANDEM DIABETES CARE INC | $4.7M | 0.54% | 245,257 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $4.5M | 0.51% | 17,022 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $3.6M | 0.41% | 94,420 | Common | SOLE |
| 81727U105 | SENS1GBP | SENSEONICS HLDGS INC | $3.1M | 0.35% | 4,657,505 | Common | SOLE |
| 25490K745 | — | DIREXION DAILY S&P BIOTECH BEAR 3X SHARES | $2.3M | 0.26% | 140,282 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $2.3M | 0.26% | 132,380 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.